Ultrasound bone mass in patients undergoing chronic therapy with oral anticoagulants

Journal of Bone and Mineral Metabolism

Volumn 29, Issue 5, 2011, Pages 546-551

  Rey Sanchez, Purificacion ^a   Lavado Garcia, Jesus Maria ^a   Canal Macias, Maria Luz ^a   Rodriguez Dominguez, Maria Trinidad ^a   Bote Mohedano, Jose Luis ^a   Pedrera Zamorano, Juan Diego ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Bone mass; Oral anticoagulants; Osteocalcin; Phalangeal bone ultrasound; Undercarboxylated osteocalcin

Indexed keywords

ACENOCOUMAROL; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ANTIVITAMIN K; OSTEOCALCIN;

AGED; AMPLITUDE MODULATION; ANTICOAGULANT THERAPY; ARTICLE; BONE DENSITY; BONE MASS; CALCANEUS; CARBOXYLATION; CONTROLLED STUDY; CORTICAL BONE; ECHOGRAPHY; FEMALE; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; PHALANX; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION ATTENUATION; THROMBOEMBOLISM; TRABECULAR BONE; VELOCITY;

ACID PHOSPHATASE; ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; BONE AND BONES; CALCANEUS; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; OSTEOCALCIN;

EID: 83155190303     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-010-0250-8     Document Type: Article

References (24)

1. Hirsh J, O'Donnell M, Weitz JI (2005) New anticoagulants. Blood 105:453-463 (Pubitemid 40070721)
2. Schalekamp T, Klungel OH, Souverein PC, de Boer A (2008) Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 168:180-185 (Pubitemid 351185885)
3. Wey PF, Petitjeans F, Lions C, Ould-Ahmed M, Escarment J (2008) Laryngeal dyspnea in relation to an interaction between acenocumarol and topical econazole lotion. Am J Geriatr Pharmacother 6:173-177
4. Rejnmark L, Vestergaard P, Mosekilde L (2007) Fracture risk in users of oral anticoagulants: a nationwide case-control study. Int J Cardiol 118:338-344 (Pubitemid 46678236)
5. Pilon D, Castilloux AM, Dorais M, LeLorier J (2004) Oral anticoagulants and the risk of osteoporotic fractures among elderly. Phamacoepidemiol Drug Saf 13:289-294 (Pubitemid 38697049)
6. Wawrzynska L, Tomkowski WZ, Przedlacki J, Hajduk B, Torbicki A (2003) Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism. Pathophysiol Haemost Thromb 33:64-67 (Pubitemid 37449280)
7. Caraballo PJ, Gabriel SE, Castro MR, Atkinson EJ, Melton LJ 3rd (1999) Changes in bone density after exposure to oral anticoagulants: a meta-analysis. Osteoporos Int 9:441-448 (Pubitemid 29231737)
8. Obrant KJ, Käkönen S-M, Astermark J, Lilja H, Lövgren T, Akesson K, Pettersson K (1999) The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarintreated patients from control subjects. J Bone Miner Res 14:555-560 (Pubitemid 29153388)
9. Horie-Inoue K, Inoue S (2008) Steroid and xenobiotic receptor mediates a novel vitamin K2 signaling pathway in osteoblastic cells. J Bone Miner Metab 26:9-12 (Pubitemid 350308005)
10. Parfitt AM (1969) Chlorothiazide induced hypercalcemia in juvenile osteoporosis and hyperparathyroidism. N Engl J Med 281:55-59
11. Rico H, Villa LF (1993) Serum tartrate-resistant acid phosphatase as a biochemical marker of bone remodelling. Calcif Tissue Int 52:149-150 (Pubitemid 23087946)
12. Descos L, Andre C, Beorghia S, Vincent C, Revillard JP (1979) Serum levels of b2-microglobulin-a new marker of activity in Crohn's disease. N Engl J Med 301:440-441 (Pubitemid 9248672)
13. Pedrera JD, Canal ML, Carvajal J, Postigo S, Villa LF, Herna ́ndez ER, Rico H (2000) Influence of vitamin D administration on bone ultrasound measurements in patients on anticonvulsant therapy. Eur J Clin Invest 30:895-899
14. Rey-Sánchez P, Lavado-Garc?́a JM, Canal-Mac?́as ML, Gómez- Zubeldia MA, Roncero-Mart?́n R, Pedrera-Zamorano JD (2009) Ultrasound bone mass in schizophrenic patients on antipsychotic therapy. Hum Psychopharmacol 24:49-54
15. Philip WJ, Martin JC, Richardson JM, Reid DM, Webster J, Doublas AS (1995) Decreased axial and peripheral bone density in patients taking long-term warfarin. QJM 88:635-640
16. Simon RR, Beaudin SM, Johnston M, Walton KJ, Shaughnessy SG (2002) Long-term treatment with sodium warfarin results in decreased femoral bone strength and cancellous bone volume in rats. Thromb Res 105:353-358 (Pubitemid 34621112)
17. Avgeri M, Papadopoulou A, Platokouki H, Douros K, Rammos S, Nicolaidou P, Aronis S (2008) Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy. J Pediatr Hematol Oncol 30:592-597
18. Pietschmann P, Woloszczuk W, Panzer S, Kyrle P, Smolen J (1988) Decreased serum osteocalcin levels in phenprocoumontreated patients. J Clin Endocrinol Metab 66:1071-1074
19. Sugiyama T, Kawai S (2001) Carboxylation of osteocalcin may be related to bone quality: a possible mechanism of bone fracture prevention by vitamin K. J Bone Miner Metab 19:146-149 (Pubitemid 32499804)
20. Liu G, Peacock M (1998) Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif Tissue Int 62:286-289 (Pubitemid 28139308)
21. Szulc P, Chapuy MC, Meunier PJ, Delmas PD (1996) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 18:487-488 (Pubitemid 26152313)
22. Schleithoff SS, Zittermann A, Stuttgen B, Tenderich G, Berthold HK, Korfer R, Stehle P (2003) Low serum levels of intact osteocalcin in patients with congestive heart failure. J Bone Miner Metab 21:247-252 (Pubitemid 41184292)
23. Lateef M, Baig M, Azhar A (2010) Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females. Osteoporos Int 21:751-755
24. Francucci CM, Ceccoli L, Rilli S, Fiscaletti P, Caudarella R, Boscaro M (2009) Skeletal effects of oral anticoagulants. J Endocrinol Invest 32:27-31